Incidence and risk factors for anastomotic stenosis of continuous hepaticojejunostomy after pancreaticoduodenectomy
Tomonari Asano(Aichi Cancer Center), Yasuhiro Shimizu(Aichi Cancer Center), Kazuo Hara(Aichi Cancer Center), Yoshiki Senda, Keitaro Matsuo(Aichi Cancer Center), Seiji Natsume(Red Cross Hospital), Kenji Yamao(Aichi Cancer Center), Seiji Ito(Aichi Cancer Center), Tsuyoshi Sano(Aichi Medical University), Yasuhiro Kodera(Nagoya Medical Center)
Cited by 45
Related Papers
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
|Gastroenterology|2015|472
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Aggressive preoperative management and extended surgery for hilar cholangiocarcinoma: Nagoya experience
|Journal of Hepato-Biliary-Pancreatic Surgery|2000|396